Enanta Pharmaceutica (ENTA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 09/30
| 06-2013 | 03-2013 | 12-2012 | 09-2012 | 06-2012 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 18,878 | 74,464 | 0 | N/A | 0 |
| Marketable Securities | 75,668 | 34,647 | 0 | N/A | 0 |
| Receivables | 1,857 | 1,437 | 0 | N/A | 0 |
| TOTAL | $97,866 | $111,664 | $0 | $N/A | $0 |
| Non-Current Assets | |||||
| PPE Net | 1,152 | 876 | N/A | N/A | N/A |
| Investments And Advances | 20,217 | 12,629 | 0 | 0 | 0 |
| Other Non-Current Assets | 436 | 458 | 0 | 0 | 0 |
| TOTAL | $21,805 | $13,963 | $N/A | $N/A | $N/A |
| Total Assets | $119,671 | $125,627 | $0 | $N/A | $0 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 918 | 2,371 | 0 | 0 | 0 |
| Accrued Expenses | 2,023 | 2,465 | 0 | N/A | 0 |
| TOTAL | $2,941 | $4,951 | $0 | $N/A | $0 |
| Non-Current Liabilities | |||||
| Deferred Revenues | N/A | 115 | N/A | N/A | N/A |
| Other Non-Current Liabilities | 2,319 | 2,301 | 0 | 0 | 0 |
| TOTAL | $2,319 | $2,301 | $N/A | $N/A | $N/A |
| Total Liabilities | $5,260 | $7,252 | $0 | $N/A | $0 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 17,912 | 17,819 | N/A | N/A | N/A |
| Common Shares | 180 | 180 | 0 | N/A | 0 |
| Retained earnings | -103,007 | -98,869 | 0 | N/A | 0 |
| Other shareholders' equity | -96 | -9 | 0 | 0 | 0 |
| TOTAL | $114,411 | $118,375 | $0 | $N/A | $0 |
| Total Liabilities And Equity | $119,671 | $125,627 | $0 | $0 | $0 |